• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Aveanna Healthcare Holdings Inc.

    5/7/25 5:47:06 PM ET
    $AVAH
    Medical/Nursing Services
    Health Care
    Get the next $AVAH alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Aveanna Healthcare Holdings Inc.

    (Name of Issuer)


    Common Stock, $.01 Par Value

    (Title of Class of Securities)


    05356F105

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    05356F105


    1Names of Reporting Persons

    PSA Healthcare Investment Holding LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    15,675,833.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    15,675,833.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    15,675,833.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox checked
    11Percent of class represented by amount in row (9)

    8.04 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    05356F105


    1Names of Reporting Persons

    J.H. Whitney VII, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    31,376,094.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    31,376,094.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    31,376,094.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox checked
    11Percent of class represented by amount in row (9)

    16.08 %
    12Type of Reporting Person (See Instructions)

    PN


    SCHEDULE 13G

    CUSIP No.
    05356F105


    1Names of Reporting Persons

    PSA Iliad Holdings LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    1,451,220.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,451,220.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,451,220.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox checked
    11Percent of class represented by amount in row (9)

    0.74 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    05356F105


    1Names of Reporting Persons

    JHW Iliad Holdings LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    5,211,091.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    5,211,091.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,211,091.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox checked
    11Percent of class represented by amount in row (9)

    2.67 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    CUSIP No.
    05356F105


    1Names of Reporting Persons

    JHW Iliad Holdings II LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    546,247.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    546,247.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    546,247.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox checked
    11Percent of class represented by amount in row (9)

    0.28 %
    12Type of Reporting Person (See Instructions)

    OO


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Aveanna Healthcare Holdings Inc.
    (b)Address of issuer's principal executive offices:

    400 Interstate North Parkway, SE, Suite 1600, Atlanta, GA 30339
    Item 2. 
    (a)Name of person filing:

    (i) PSA Healthcare Investment Holding LLC is a Delaware limited liability company whose managing member is Whitney Strategic Partners VII, L.P., a Delaware limited partnership. The name of the general partner of Whitney Strategic Partners VII, L.P. is J.H. Whitney Equity Partners VII, LLC, a Delaware limited liability company, whose business address is 212 Elm Street, New Canaan, CT 06840. The names of the members of J.H. Whitney Equity Partners VII, LLC are Paul R. Vigano and Robert M. Williams, Jr., the business address of each of whom is 212 Elm Street, New Canaan, CT 06840. (ii) J.H. Whitney VII, L.P. is a Delaware limited partnership. The name of the general partner of J.H. Whitney VII, L.P. is J.H. Whitney Equity Partners VII, LLC, a Delaware limited liability company, whose business address is 212 Elm Street, New Canaan, CT 06840. Paul R. Vigano and Robert M. Williams, Jr., the business address of each of whom is 212 Elm Street, New Canaan, CT 06840, are the members of J.H. Whitney Equity Partners VII, LLC. (iii) PSA Iliad Holdings LLC is a Delaware limited liability company whose managing member is Whitney Strategic Partners VII, L.P., a Delaware limited partnership. The name of the general partner of Whitney Strategic Partners VII, L.P. is J.H. Whitney Equity Partners VII, LLC, a Delaware limited liability company, whose business address is 212 Elm Street, New Canaan, CT 06840. Paul R. Vigano and Robert M. Williams, Jr., the business address of each of whom is 212 Elm Street, New Canaan, CT 06840, are the members of J.H. Whitney Equity Partners VII, LLC. (iv) JHW Iliad Holdings LLC is a Delaware limited liability company. The name of the managing member of JHW Iliad Holdings, LLC is Project Iliad Managing Member, LLC, a Delaware limited liability company, whose business address is 212 Elm Street, New Canaan, CT 06840. Paul R. Vigano and Robert M. Williams, Jr., the business address of each of whom is 212 Elm Street, New Canaan, CT 06840, are members of Project Ilian Managing Member, LLC. (v) JHW Iliad Holdings II LLC is a Delaware limited liability company whose managing member is J.H. Whitney VII Management Co., LLC, a Delaware limited liability company. The sole member of such managing member is J.H. Whitney Capital Partners, LLC, a Delaware limited liability company. The business address of such entities is 212 Elm Street, New Canaan, CT 06840. Paul R. Vigano and Robert M. Williams, Jr., the business address of each of whom is 212 Elm Street, New Canaan, CT 06840, are the members of J.H. Whitney Capital Partners, LLC.
    (b)Address or principal business office or, if none, residence:

    (i) PSA Healthcare Investment Holding LLC 212 Elm Street New Canaan, CT 06840 (ii) J.H. Whitney VII, L.P. 212 Elm Street New Canaan, CT 06840 (iii) PSA Iliad Holdings LLC 212 Elm Street New Canaan, CT 06840 (iv) JHW Iliad Holdings LLC 212 Elm Street New Canaan, CT 06840 (v) JHW Iliad Holdings II LLC 212 Elm Street New Canaan, CT 06840
    (c)Citizenship:

    (i) PSA Healthcare Investment Holding LLC is a Delaware limited liability company. Its managing member is a Delaware limited partnership whose general partner is a Delaware limited liability company. All of the individual members of such general partner are citizens of the United States. (ii) J.H. Whitney VII, L.P. is a Delaware limited partnership. Its general partner is a Delaware limited liability company. All of the individual members of such general partner are citizens of the United States. (iii) PSA Iliad Holdings LLC is a Delaware limited liability company. Its managing member is a Delaware limited partnership whose general partner is a Delaware limited liability company. All of the individual members of such general partner are citizens of the United States. (iv) JHW Iliad Holdings LLC is a Delaware limited liability company. Its managing member is a Delaware limited liability company. All of the individual members of the managing member are citizens of the United States. (v) JHW Iliad Holdings II LLC is a Delaware limited liability company. Its managing member is a Delaware limited liability company. The sole member of such managing member is a Delaware limited liability company. All of the individual members of such sole member are citizens of the United States.
    (d)Title of class of securities:

    Common Stock, $.01 Par Value
    (e)CUSIP No.:

    05356F105
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    (i) PSA Healthcare Investment Holding LLC is the beneficial owner of 15,675,833 shares.1 (ii) J.H. Whitney VII, L.P. is the beneficial owner of 31,376,094 shares.1 (iii) PSA Iliad Holdings LLC is the beneficial owner of 1,451,220 shares.1 (iv) JHW Iliad Holdings LLC is the beneficial owner of 5,211,091 shares.1 (v) JHW Iliad Holdings II LLC is the beneficial owner of 546,247 shares.1 1 PSA Healthcare Investment Holding LLC, J.H. Whitney VII, L.P., PSA Iliad Holdings LLC, JHW Iliad Holdings LLC and JHW Iliad Holdings II, LLC disclaim the existence of a group with respect to the Common Stock of the issuer, and each disclaims beneficial ownership of the shares of Common Stock owned by the others.
    (b)Percent of class:

    (i) 8.04% for PSA Healthcare Investment Holding LLC; (ii) 16.08% for J. H. Whitney VII, L.P.; (iii) 0.74% for PSA Iliad Holdings LLC; (iv) 2.67% for JHW Iliad Holdings LLC; and (v) 0.28% for JHW Iliad Holdings II LLC.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    15,675,833 shares for PSA Healthcare Investment Holding LLC; 31,376,094 shares for J.H. Whitney VII, L.P.; 1,451,220 shares for PSA Iliad Holdings LLC; 5,211,091 shares for JHW Iliad Holdings LLC; and 546,247 shares for JHW Iliad Holdings II LLC.

     (ii) Shared power to vote or to direct the vote:

    0 shares for PSA Healthcare Investment Holding LLC; 0 shares for J. H. Whitney VII, L.P.; 0 shares for PSA Iliad Holdings LLC; 0 shares for JHW Iliad Holdings LLC; and 0 shares for JHW Iliad Holdings II LLC.

     (iii) Sole power to dispose or to direct the disposition of:

    15,675,833 shares for PSA Healthcare Investment Holding LLC; 31,376,094 shares for J.H. Whitney VII, L.P.; 1,451,220 shares for PSA Iliad Holdings LLC; 5,211,091 shares for JHW Iliad Holdings LLC; and 546,247 shares for JHW Iliad Holdings II LLC.

     (iv) Shared power to dispose or to direct the disposition of:

    0 shares for PSA Healthcare Investment Holding LLC; 0 shares for J. H. Whitney VII, L.P.; 0 shares for PSA Iliad Holdings LLC; 0 shares for JHW Iliad Holdings LLC; and 0 shares for JHW Iliad Holdings II LLC. PSA Healthcare Investment Holding LLC, J.H. Whitney VII, L.P., PSA Iliad Holdings LLC, JHW Iliad Holdings LLC and JHW Iliad Holdings II, LLC (collectively, the "J.H. Whitney Parties") are, together with the funds and entities advised by Bain Capital Investors, LLC (the "Bain Capital Parties"), parties to a stockholders' agreement (the "Stockholders Agreement") with respect to their respective investments in the Issuer. Among other things, the Stockholders Agreement obligates the J.H. Whitney Parties and the Bain Capital Parties to vote their shares of the Issuer's common stock in favor of each other's director nominees and coordinate transfers of their respective shares of the Issuer's common stock. By virtue of the Stockholders Agreement and the obligations and rights thereunder, the Reporting Persons in this Schedule 13G and the Bain Capital Parties may be deemed to constitute a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Based on available information, such a "group" would be deemed to beneficially own approximately 135,861,365 shares, which represents approximately 69.64% shares of the Issuer's common stock, calculated pursuant to Rule 13d-3. The Reporting Persons expressly disclaim beneficial ownership of, and the responses to Items 5 through 9 of the cover pages to this Schedule 13G do not reflect, any shares of the Issuer's common stock that the Reporting Persons may be deemed to beneficially own solely by reason of the Stockholders Agreement.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    No other person has the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the securities owned by PSA Healthcare Investment Holding LLC, J. H. Whitney VII, L.P., PSA Iliad Holdings LLC, JHW Iliad Holdings LLC, and JHW Iliad Holdings II LLC.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    Not Applicable

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    PSA Healthcare Investment Holding LLC
     
    Signature:/s/ David Zatlukal
    Name/Title:Vice President
    Date:05/07/2025
     
    J.H. Whitney VII, L.P.
     
    Signature:/s/ David Zatlukal
    Name/Title:Vice President
    Date:05/07/2025
     
    PSA Iliad Holdings LLC
     
    Signature:/s/ David Zatlukal
    Name/Title:Vice President
    Date:05/07/2025
     
    JHW Iliad Holdings LLC
     
    Signature:/s/ David Zatlukal
    Name/Title:Vice President
    Date:05/07/2025
     
    JHW Iliad Holdings II LLC
     
    Signature:/s/ David Zatlukal
    Name/Title:President
    Date:05/07/2025
    Get the next $AVAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVAH

    DatePrice TargetRatingAnalyst
    12/13/2023Neutral → Underweight
    JP Morgan
    11/30/2023$1.50Sell
    UBS
    5/12/2023Strong Buy → Mkt Perform
    Raymond James
    1/27/2023$2.00 → $1.00Neutral → Underperform
    Credit Suisse
    11/21/2022$7.00 → $3.00Outperform → Sector Perform
    RBC Capital Mkts
    11/17/2022$5.50 → $2.00Outperform → Neutral
    Credit Suisse
    7/22/2022$2.50Buy → Hold
    Jefferies
    7/5/2022Buy → Hold
    Truist
    More analyst ratings

    $AVAH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

      First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

      5/8/25 6:30:59 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna to Participate at the RBC 2025 Global Healthcare Conference

      ATLANTA, April 29, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the RBC 2025 Global Healthcare Conference in New York on May 20, 2025. Management will host 1x1 investor meetings as well as a fireside chat at 11:30 a.m. Eastern Time on the same day, May 20, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthcare is headquart

      4/29/25 7:30:32 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna to Participate at the Bank of America Securities 2025 Health Care Conference

      ATLANTA, April 22, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Bank of America Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. Management will host 1x1 investor meetings as well as a presentation at 3:15 p.m. Pacific Time on the same day, May 14, 2025. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company's website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call. About Aveanna Healthcare Aveanna Healthc

      4/22/25 7:30:52 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    SEC Filings

    See more
    • Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

      5/9/25 3:30:09 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

      5/9/25 7:30:14 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Aveanna Healthcare Holdings Inc.

      10-Q - Aveanna Healthcare Holdings, Inc. (0001832332) (Filer)

      5/8/25 6:30:18 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $AVAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $AVAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Large owner J.H. Whitney Equity Partners Vii, Llc sold $102,489 worth of shares (18,204 units at $5.63) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      4/3/25 6:09:43 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Large owner Williams Robert M Jr sold $114,424 worth of shares (20,324 units at $5.63) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      4/3/25 6:04:16 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Large owner Vigano Paul R sold $114,424 worth of shares (20,324 units at $5.63) (SEC Form 4)

      4 - Aveanna Healthcare Holdings, Inc. (0001832332) (Issuer)

      4/3/25 6:00:17 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

      SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      2/14/24 4:00:42 PM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Aveanna Healthcare Holdings Inc.

      SC 13G - Aveanna Healthcare Holdings, Inc. (0001832332) (Subject)

      2/14/22 6:43:51 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna downgraded by JP Morgan

      JP Morgan downgraded Aveanna from Neutral to Underweight

      12/13/23 6:49:11 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • UBS initiated coverage on Aveanna with a new price target

      UBS initiated coverage of Aveanna with a rating of Sell and set a new price target of $1.50

      11/30/23 7:52:45 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna downgraded by Raymond James

      Raymond James downgraded Aveanna from Strong Buy to Mkt Perform

      5/12/23 7:24:50 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Financials

    Live finance-specific insights

    See more
    • Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook

      First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared to net loss of $11.2 million for the comparable prior year period Adjusted Net income was $21.4 million, an increase of $27.1 million compared to Q1 2024 Adjusted EBITDA for Q1 2025 was $67.4 million, a 93.1% increase as compared to Q1 2024Revised Full Year 2025 Revenue guidance greater than $2.15 billion, updated from a range of $2.10 - $2.12 billion Revised Full Year 2025 Adjusted EBITDA guidance greater than $207 million, updated from a range of $190 - $194 million ATLANTA, May 08, 20

      5/8/25 6:30:59 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Announces First Quarter 2025 Earnings Release Date and Conference Call

      ATLANTA, April 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 8, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13752435. The replay will be available until May 15, 2025. Int

      4/17/25 6:30:46 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Outlook

      Fourth Quarter Revenue was $519.9 million, an 8.6% increase over the prior year period Gross margin increased 15.7% to $171.7 million compared to Q4 2023 Fourth Quarter Net income was $29.2 million compared to net loss of $25.7 million for the comparable prior year period Adjusted Net income was $11.1 million, an increase of $14.3 million compared to Q4 2023 Adjusted EBITDA for Q4 2024 was $55.2 million, a 42.8% increase as compared to Q4 2023Full Year 2025 Revenue guidance between $2.10 - $2.12 billion Full Year 2025 Adjusted EBITDA guidance between $190 - $194 million ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:A

      3/13/25 6:30:16 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care

    $AVAH
    Leadership Updates

    Live Leadership Updates

    See more
    • Aveanna Healthcare Holdings Announces Appointment of New Director

      ATLANTA, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Brent Layton to serve as a Class III director of the Board of Directors of Aveanna Healthcare Holdings Inc., and additionally as a member of the Audit Committee of the Board, effective November 1, 2024. "I am delighted to announce the appointment of Brent Layton to our Aveanna Board of Directors. Brent brings a wealth of healthcare knowledge from over 20 years of leadership at Centene Corporation. Brent's experience working with state and feder

      11/4/24 7:30:02 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

      ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. "I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role. Jerry has a strong background in corporate law and a wealth of healthcare industry and regulatory experience. I have known Jerry for more than a decade and have great trust in his leadership and counsel. It is a pleasure to welcome Jerry to our Aveanna family, and

      4/3/24 6:30:06 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care
    • Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer

      ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023. "I am pleased to announce the promotion of Matt to the Chief Financial Officer position. Matt has provided strong financial leadership and continuity as we build on our recent successes to t

      12/11/23 7:30:00 AM ET
      $AVAH
      Medical/Nursing Services
      Health Care